Results 231 to 240 of about 254,005 (338)

An individual treatment effect approach to predict response to mineralocorticoid receptor antagonists in patients with heart failure and reduced ejection fraction

European Journal of Heart Failure, EarlyView.
Aims Mineralocorticoid receptor antagonists (MRAs) are often underused in patients with heart failure (HF) and reduced ejection fraction (HFrEF). Individual treatment effect (ITE) may assist physicians in making timely decisions about which patients are the best suited for personalized therapy.
Masatake Kobayashi, Kevin Duarte, João Pedro Ferreira, Guillaume Baudry, Luca Monzo, John J.V. McMurray, Dirk J Van Veldhuisen, Bertram Pitt, Faiez Zannad, Nicolas Girerd   +9 more
wiley   +1 more source

Renin-Angiotensin System Autoantibody Network in Parkinson's Disease Patients. [PDF]

Antioxidants (Basel)
Labandeira CM, Camacho-Meño L, Aracil-Pastor P, Suárez-Quintanilla JA, Labandeira-García JL, Rodríguez-Pérez AI.   +5 more
europepmc   +1 more source

Cardiorenal disease development under chronic renin–angiotensin–aldosterone system suppression

, 2012
Pantelis Sarafidis, Luís M. Ruilope
openalex   +2 more sources

Global patterns of polypharmacy after acute heart failure hospitalization: Prevalence and outcomes from the REPORT‐HF registry

European Journal of Heart Failure, EarlyView.
Global patterns of polypharmacy after acute heart failure hospitalization. GDMT, guideline‐directed medical therapy; HF, heart failure. Aims Polypharmacy, defined as the concurrent use of ≥5 medications, is prevalent among older adults with heart failure (HF).
Wan Ting Tay, Tiew‐Hwa Katherine Teng, Wouter Ouwerkerk, John G.F. Cleland, Sean P. Collins, Christiane E. Angermann, Kenneth Dickstein, Ulf Dahlstrom, Anja Schweizer, Achim Obergfell, Kai‐Hang Yiu, Mathieu Ghadanfar, Mahmoud Hassanein, Qing‐Wen Ren, Wen‐Li Gu, Georg Ertl, Sergio V. Perrone, Gerasimos Filippatos, Carolyn S.P. Lam, Jasper Tromp   +19 more
wiley   +1 more source

A U‐shaped relationship between left ventricular ejection fraction and risk of worsening heart failure

European Journal of Heart Failure, EarlyView.
A U‐shaped relationship between left ventricular ejection fraction (LVEF) and clinical outcomes. A U‐shaped relationship can be observed between LVEF, the primary outcome, and the cardiovascular‐related outcomes, including cardiovascular death and the risk of worsening heart failure (HF).
Hao‐Chih Chang, Wei‐Ming Huang, Liang‐Yin Lin, Ching‐Wei Lee, Chih‐Hsueh Tseng, Wen‐Chung Yu, Hao‐Min Cheng, Chern‐En Chiang, Chen‐Huan Chen, Shih‐Hsien Sung   +9 more
wiley   +1 more source

A comparison of drugs targeting the renin-angiotensin system and global cognition in aging. [PDF]

J Alzheimers Dis
George CJ, Kyaw KT, Hall CB, Weiss EF, Verghese J, Abadir P.   +5 more
europepmc   +1 more source

European Journal of Heart Failure consensus statement. Heart failure pharmacotherapy for patients with heart failure with reduced ejection fraction and concomitant atrial fibrillation: Review of evidence and call to action

European Journal of Heart Failure, EarlyView.
Heart failure (HF) and atrial fibrillation (AF) are major global health challenges with rising prevalence and significant morbidity, mortality, and healthcare burden. Despite advances in HF management, AF remains a critical comorbidity that worsens outcomes and requires ad hoc treatment strategies, increasing the risk of non‐adherence and side effects.
Mark Luedde, Stefan Agewall, Giuseppe Ambrosio, Antoni Bayes‐Genis, Claudio Borghi, Elisabetta Cerbai, Gheorghe A. Dan, Heinz Drexel, Péter Ferdinandy, Erik Lerkevang Grove, Juan Carlos Kaski, Roland Klingenberg, Joao Morais, William Parker, Mark C. Petrie, Bianca Rocca, Anne Grete Semb, Michele Senni, Christian Sohns, Patrick Sulzgruber, Juan Tamargo, Marco Metra, Michael Böhm, Dobromir Dobrev, Samuel Sossalla   +24 more
wiley   +1 more source

Localization and Expression of Renin-Angiotensin System Receptors in Lung from Transplant Patients: A Case-Control Study. [PDF]

Biomedicines
Silveira AT, Fagundes LS, Flor J, Martins IA, Otero LB, Marques da Silva LT, Maciel LS, Eller S, Guimarães GR, Perin FA, Wink MR, Rigatto K.   +11 more
europepmc   +1 more source

Systemic candesartan reduces brain angiotensin II via downregulation of brain renin–angiotensin system [PDF]

, 2009
Nicolas Pelisch, Naohisa Hosomi, Masaki Ueno, Hisashi Masugata, Koji Murao, Hirofumi Hitomi, Daisuke Nakano, Hiroyuki Kobori, Akira Nishiyama, Masakazu Kohno   +9 more
openalex   +1 more source

Novel inhibitors of the cellular renin‐angiotensin system components, poricoic acids, target Smad3 phosphorylation and Wnt/β‐catenin pathway against renal fibrosis

British Journal of Pharmacology, 2018
Ming Wang, Dan-Qian Chen, Lin Chen, Gang Cao, Hui Zhao, Dan Liu, N. Vaziri, Yan Guo, Ying-yong Zhao   +8 more
semanticscholar   +1 more source